.png){kind=icon}
.png){kind=icon}
Return
Incretin-based therapy and Parkinson's disease risk among patients with type 2 diabetes: Retrospective cohort study and meta-analysis
.png){kind=icon}
PRE
AI
Y
T
G
G
N
DOI：10.1016/j.parkreldis.2025.108171.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• IBT, a common treatment of T2D and weight, may have neuroprotective features. • A large retrospective cohort study and meta-analysis were conducted for robustness • IBT use was associated with a 30% reduced PD risk • IBT effect was more pronounced in young subjects and those with short T2D duration • A potential neuroprotective effect of IBT on PD risk among patients with T2D
Journal
P
IF:
3.4
Papers:
7.3K
Citations:
1.3W
Organization
Cited Papers